Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia
Titel:
Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia
Auteur:
Brass, Eric P. Anthony, Richard Dormandy, John Hiatt, William R. Jiao, Jenny Nakanishi, Atsushi McNamara, Thomas Nehler, Mark